DAVID SMITH: Open Payments
NPI 1306471297 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,295 in 57 payments from 27 companies in 2025. Trend: 2023 $860 · 2024 $721 · 2025 $1,295
Food & beverage: $1,295
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 10 | $251 |
| Lilly USA, LLC | 6 | $121 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| Janssen Biotech, Inc. | 4 | $81 |
| Genentech USA, Inc. | 4 | $65 |
| Eisai Inc. | 2 | $53 |
| Incyte Corporation | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Daiichi Sankyo Inc. | 2 | $39 |
Products named: KEYTRUDA, VERZENIO, KISQALI, ENHERTU, Lenvima, JAKAFI, OJJAARA, OPDIVO.
Industry payments across MI — which companies pay providers there.
